Bri Bronsky, Cristin Adams, and Corinne McGill

Slides:



Advertisements
Similar presentations
EPIDEMIOLOGY AND GENETICS OF ALZHEIMER´S DISEASE
Advertisements

Risk Factors in a Group of Puerto Rican Patients with Alzheimer’s Dementia Heriberto A. Acosta M.D.¹ Irving Vega Ph.D.² Clara Camacho M.S.² ¹Judith Irizarry.
Epidemiology of Dementia in Canada: Information from the Canadian Study of Health and Aging.
MILD COGNITIVE IMPAIRMENT IN PATIENTS WITH CAROTID DISEASE Irena Martinic Popovic 1, M.D, Arijana Lovrencic-Huzjan 1, M.D, Ph. D, Ana-Maria Simundic 2,
Glucose Levels and Risk of Dementia Presented by - Anas Kabaha, MD Sheba medical center Sheba medical center August 8,2013.
SYNOPSIS OF THE PROTOCOL Title: Pregnancy Associated Breast Cancer (PABC); Prospective Data Registry in Saudi Arabia Sponsor: Oncology Department, King.
Katy L. Gordon, BSN, RN What are the Statistics? Centers for Disease Control (2009). Adult obesity: Obesity rises among adults.
Alzheimer’s Assessment Assessing the Cognitive-Linguistic effects of Alzheimer’s.
Diabetes: The Modern Epidemic Roy Buchinsky, MD Director of Wellness.
Epidemiology of CVD in the Elderly Karen P. Alexander MD Duke University Medical Center Duke Clinical Research Institute Disclosures: (1) Minor Research:
How to diagnose dementia? Dr. Sridhar Vaitheswaran 25 th October 2012.
Adverse Outcomes After Hospitalization and Delirium in Persons with Alzheimer Disease Charles Wang, PharmD Candidate.
Type 1, Type 2 and Prevention
Diabetes Update Division of Endocrinology Department of Medicine Wayne State University Medical School Detroit, Michigan Part 1 of 3.
PZP: A novel biomarker for early Alzheimer’s disease ? Diana A.T. Nijholt Department of Neurology Laboratory for Clinical and Cancer Proteomics
Peripheral and Central Nervous System Drugs Advisory Committee Meeting - March 14, Issues Related to the Development of Drugs for the Treatment.
Healthy Women Healthy Lives March 18, 2014 Healthy in America in 2014 and Beyond.
Preoperative Hemoglobin A1c and the Occurrence of Atrial Fibrillation Following On-pump Coronary Artery Bypass surgery in Type-2 Diabetic Patients Akbar.
The Alzheimer’s Disease Challenge: Take Your Knowledge Further ALZHEIMER’S DISEASE AND ITS MANAGEMENT: AN OVERVIEW.
Dr. Nadira Mehriban. INTRODUCTION Diabetic retinopathy (DR) is one of the major micro vascular complications of diabetes and most significant cause of.
1 Predicting Dementia From Vascular Conditions Among Tennessee Medicare Elderly Baqar A. Husaini, PhD Professor & Director, Center for Health Research.
Epidemiological Methods Duanping Liao, MD, Ph.D Professor and Vice Chair for Research Chief, Division of Epidemiology Department of Public Health Sciences.
Dementia Jaqueline Raetz, M.D.. Types of Dementia Alzheimer Dementia 70% Lewy Body Dementia about 22% Vascular Dementia 17% Frontotemporal Dementia Overall.
Dementia Jaqueline Raetz, M.D..
C Wilson, KM Rhodes, RA Payne
Basics of New PHASE Reporting
Longitudinal course of cognition in elderly subjects with Mild Parkinsonian Signs Stefanie Lerche1,2, Kathrin Brockmann1,2, Andrea Pilotto1,3, Isabel Wurster1,2,
Comparison of three Observational Analytical strategies
Lisa A. Weissfeld Professor and Associate Chair Dept. of Biostatistics
Could Cooked Meat Hold A Risk Factor For Dementia And Diabetes?
Dementia Jaqueline Raetz, M.D..
Dr Gayan Perera Epidemiologist
Journal Club Anitha Bhat December 20, 2013.
Copyright © 2007 American Medical Association. All rights reserved.
The Anglo Scandinavian Cardiac Outcomes Trial
Image Challenge Q: A 70-year-old woman presented to the neurology clinic with a 2-year history of gait disturbance, cognitive impairment, and urinary incontinence.
21 September 2018 A meta-analysis of the effects of overweight and obesity on endometrial cancer Jalal Poorolajal (MD, MPH, PhD) Associate Professor of.
Cognitive Disorders and Aging
Amphitheater Public Schools
Epilepsy in Diagnostic Imaging
From the Indianapolis – Ibadan Dementia Research Project.
Essential Updates in Atopic Dermatitis:
Best Practices to Simplify and Optimize
Prospective Cohort Study (Click or press Enter to follow animation)
Early Dementia Distinguishing AD From MCI
Section VII: Summary New focus on treating hypertension beyond the numbers Content Points: In view of current clinical understanding of the link between.
Annals of Internal Medicine • Vol. 167 No. 12 • 19 December 2017
Evaluating the cost-effectiveness of interventions with an impact on ageing P. Breeze, P. Thokala, L. Lafortune, C. Brayne, A. Brennan 07/12/2018.
John F. Crary, MD-PhD Associate Professor
The Research Question Aim TIA is defined by short-lasting symptoms
Summer School on Neuroscience & Aging
Introduction to AD. Practical Approaches to the Identification of Alzheimer Disease in Primary Care.
Publishing Nutrition Research: A Review of Epidemiologic Methods
Sample size.
Manjula Kurella Tamura, Kristine Yaffe  Kidney International 
Prospective Cohort Study of Body Image Disturbance in Surgically-Managed Head and Neck Cancer Patients Evan Graboyes MD Department of Otolaryngology-Head.
Baseline Characteristics of the Subjects
Excessive Daytime Sleepiness & Depression
PrEP and Condom Use Keri Broadley and John Del Gaizo.
Adam Brickler, Psy.D. March 1, 2019
The Heart Truth Delaware Background
SYNOPSIS OF THE PROTOCOL
Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley 
Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.
II PAHO-DOTA Workshop on Quality of Care of Diabetes Care
Alzheimer's Prevention Research and
Ongoing Research With Vascular Risk Factors and the RAS in Individuals at Risk for AD Whitney Wharton, PhD Assistant Professor,
in Younger and Older African Americans and Whites
ACT on Alzheimer’s Disease Curriculum
Generating reliable evidence on the determinants of NCDs
Presentation transcript:

Bri Bronsky, Cristin Adams, and Corinne McGill The Link Between Poorly Controlled Type II Diabetes and Alzheimer’s Disease Bri Bronsky, Cristin Adams, and Corinne McGill

Poorly Controlled Type 2 Diabetes = Risk of Alzheimer’s Disease Study Question Does poorly controlled type 2 diabetes increase the risk of developing Alzheimer’s disease in adults aged 65-75 compared to those with controlled diabetes? Hypothesis H0: Rexp= Runexp HA: Rexp> Runexp Poorly Controlled Type 2 Diabetes = Risk of Alzheimer’s Disease

Exposure Outcome Uncontrolled Diabetes (A1C > 9 ) Clinical Diagnosis of Alzheimer’s Disease

Study Design - Prospective Cohort Diabetic Positron emission tomography (PET)

Data Analysis Main exposure: uncontrolled or controlled DM Dichotomous variable Primary outcome: diagnosis of AD or no diagnosis of AD Measure of association: risk ratio Runcontrolled DM/ Rcontrolled DM Covariates Hypertension, hyperlipidemia, obesity, family history of AD Sample size estimate: 47,180 individuals (see next slide)

From https://www.openepi.com/SampleSize/SSCohort.htm

Problems, Pitfalls, Limitations High cost given numbers and proposed testing Large number of people required given relatively low incidence AD Variable blood sugar control over time Medication differences Patients inevitably lost to follow up Those with dementia may be more likely to be lost to follow up Bias is toward the null

References American Diabetes Association. (2018, March 22). Diabetes Statistics about Diabetes. http://www.diabetes.org/diabetes-basics/statistics/ Keene, C.D., Montine, T.J., Kuller, A.H. (2018). Epidemiology, pathology, and pathogenesis of Alzheimer disease. Wilterdink, J.L. (Ed.), UpToDate. Retrieved October 29, 2018, from https://www.uptodate.com/contents/epidemiology-pathology-and-pathogenesis-of-alzheimer-disease A1C test. (2018, April 05). Retrieved from https://www.mayoclinic.org/tests-procedures/a1c-test/about/pac-20384643 Weintraub S, Salmon D, Mercado N, … Morris JC. (2009). The Alzheimer’s disease centers’ Uniform Data Set (UDS): The Neuropsychologic Test Battery. Alzheimer Dis Assoc Disord, 23(2), 91-101. Hachinski V, Iadecola C, Petersen RC, … Leblanc GG. (2006). National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment harmonization standards. Stroke, 37, 2220-41.